全文获取类型
收费全文 | 474篇 |
免费 | 17篇 |
国内免费 | 22篇 |
专业分类
儿科学 | 27篇 |
基础医学 | 43篇 |
口腔科学 | 9篇 |
临床医学 | 52篇 |
内科学 | 73篇 |
皮肤病学 | 3篇 |
神经病学 | 1篇 |
特种医学 | 184篇 |
外科学 | 24篇 |
综合类 | 2篇 |
预防医学 | 14篇 |
眼科学 | 7篇 |
药学 | 44篇 |
肿瘤学 | 30篇 |
出版年
2023年 | 1篇 |
2021年 | 4篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 4篇 |
2017年 | 1篇 |
2015年 | 2篇 |
2014年 | 2篇 |
2013年 | 12篇 |
2012年 | 2篇 |
2011年 | 4篇 |
2010年 | 11篇 |
2009年 | 9篇 |
2008年 | 8篇 |
2007年 | 22篇 |
2006年 | 8篇 |
2005年 | 13篇 |
2004年 | 7篇 |
2003年 | 6篇 |
2002年 | 3篇 |
2001年 | 9篇 |
2000年 | 5篇 |
1999年 | 3篇 |
1998年 | 32篇 |
1997年 | 44篇 |
1996年 | 25篇 |
1995年 | 27篇 |
1994年 | 19篇 |
1993年 | 12篇 |
1992年 | 3篇 |
1991年 | 8篇 |
1990年 | 10篇 |
1989年 | 19篇 |
1988年 | 25篇 |
1987年 | 16篇 |
1986年 | 18篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 16篇 |
1981年 | 7篇 |
1980年 | 15篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1976年 | 14篇 |
1975年 | 4篇 |
排序方式: 共有513条查询结果,搜索用时 15 毫秒
101.
Drobyski WR; Ash RC; Casper JT; McAuliffe T; Horowitz MM; Lawton C; Keever C; Baxter-Lowe LA; Camitta B; Garbrecht F 《Blood》1994,83(7):1980-1987
Between January 1988 and March 1993, 48 patients received T-cell- depleted marrow grafts from unrelated donors as treatment for chronic myelogenous leukemia (CML). The median age of the population was 31.7 years (range 5.4 to 53) with 17 of 48 patients greater than 40 years of age. Twenty-seven patients were transplanted in chronic phase, 17 in accelerated phase, and 4 in blast crisis. All patients received a standardized preparative regimen of cyclophosphamide, high-dose cytosine arabinoside, methylprednisolone, and total body irradiation. Marrow grafts were depleted of mature T cells with the alpha beta T- cell receptor antibody T10B9 as graft-versus-host disease (GVHD) prophylaxis. All patients also received posttransplant cyclosporine therapy. Twenty-eight of 48 patients were mismatched with their donors for one or more HLA-A, B, DR, or DQ loci by either serology or high- resolution oligonucleotide genotyping. Nine of 28 were mismatched at multiple HLA loci. Durable engraftment was achieved in 94% (45/48) of patients. The actuarial probability of developing grades II to IV and grades III to IV acute GVHD were 39.6% (95% confidence interval (CI) 26.9 to 53.0) and 8.3% (95% CI 6.1 to 10.9) for the entire cohort. There was no difference in the incidence of grades II to IV acute GVHD between patients receiving matched (36.8%) or mismatched (41.4%) marrow grafts (P = .77). The actuarial probability of relapse at 2 years was 8.8% (95% CI 2.1 to 21.6) for the entire cohort and 18% (95% CI 4 to 41) for patients transplanted in either the accelerated or blast crisis phase (advanced disease). One cytogenetic relapse has occurred among patients transplanted in the chronic phase. The probability of disease- free survival at 2 years was 52% (95% CI 24 to 70) for patients transplanted in chronic phase and 46% (95% CI 25 to 73) for patients transplanted with advanced disease. No difference in disease-free survival was observed between patients receiving matched (49%) or mismatched (51%) marrow grafts (P = .90). This study shows that patients receiving unrelated T-cell-depleted marrow grafts for CML can achieve durable engraftment with a low incidence of severe GVHD and apparent preservation of graft-versus-leukemia reactivity. These data also suggest that T-cell depletion may allow patients who might otherwise experience unacceptable toxicity from GVHD-related complications caused by older age or increased HLA disparity to benefit from unrelated marrow grafts. 相似文献
102.
Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan 总被引:2,自引:0,他引:2
BACKGROUND: The prevalence of hepatitis G virus (HGV) and its strain variant, the GB agent (GBV-C) is high in non-virus-inactivated plasma products, but, persistent infection in recipients is relatively low. STUDY DESIGN AND METHODS: Stored samples from transfusion donors and recipients in a prospective study of posttransfusion hepatitis were tested for HGV RNA and antibody to the E2 protein (anti-E2). RESULTS: Thirty-two (2.1%) of the 1500 qualified donors were positive for HGV RNA. Twenty-four persons had received a transfusion of blood from one of these 32 viremic donors. Of these 24 recipients, 3 were positive for HGV RNA before transfusion. Of the remaining 21 recipients, 8 became viremic after transfusion, while the other 13 were not infected. Four of the eight infected recipients were persistently positive for HGV RNA, while four became negative in 1 to 3 years. Three of the four patients with HGV clearance seroconverted to anti-E2 positivity. Comparison of the viral titer, viral sequences at E2, storage period of blood donations, and clinical data in the infected and noninfected recipients revealed no significant differences. However, the noninfected recipients seemed to have a higher prevalence of anti-E2 before transfusion. CONCLUSION: The prevalence of HGV viremia in volunteer blood donors in Taiwan is 2.1 percent, and blood from 0.6 percent of them actually causes HGV infection in the recipients. In half of infected recipients, clearance of HGV occurs. Anti-E2 appears in most recipients whose viremia is cleared. 相似文献
103.
104.
Ton AF Lenssen Mike JA van Steyn Yvonne HF Crijns Eddie MH Waltjé George M Roox Ruud JT Geesink Piet A van den Brandt Rob A De Bie 《BMC musculoskeletal disorders》2008,9(1):60
Background
Adequate and intensive rehabilitation is an important requirement for successful total knee arthroplasty. 相似文献105.
丹酚酸A对小鼠脑缺血再灌注致学习记忆功能障碍的改善作用及作用机制 总被引:24,自引:0,他引:24
本实验采用脑缺血再灌注损伤造成小鼠学习记忆功能障碍模型。通过跳台和避暗实验法研究了丹酚酸对记忆获得功能障碍的改善作用。结果表明丹酚酸A3,10mg·kg-1iv可以减轻脑缺血再灌注导致的小鼠学习记忆功能障碍状态。并使小鼠脑缺血再灌注后脑组织中脂质过氧化产物MDA含量明显降低。体外实验表明丹酚酸A10-8~10-7’mol·L-1可以抑制大鼠脑组织匀浆脂质过氧化反应和羟自由基(·OH)的生成,表现出较强的抗氧化作用,提示丹酚酸改善脑缺血再灌注损伤的主要机制可能与其抗氧化作用有关。 相似文献
106.
Olubuyide IO; Ola SO; Aliyu B; Dosumu OO; Arotiba JT; Olaleye OA; Odaibo GN; Odemuyiwa SO; Olawuyi F 《QJM : monthly journal of the Association of Physicians》1997,90(6):417-422
We surveyed a random sample (n = 75) of doctors and dentists at University
College Hospital, Ibadan, Nigeria. They were offered anonymous testing for
hepatitis B surface antigen (HBsAg), hepatitis Be antigen (HBeAG),
antibodies to hepatitis B core antigen (anti-HBc) and to hepatitis C virus
(anti-HCV), by enzyme immunoassay. The results suggest a high prevalence of
hepatitis B virus (HBV) with a high potential of transmissibility, as well
as a high prevalence of HCV infection. The majority of the doctors and
dentists use universal precaution for protection against viral hepatitis on
< 50% of the occasions when they carry out procedures on their patients.
Infection with HBV was associated with type of specialty (surgeons,
dentists) and lack of HBV vaccination (p < 0.05). After logistic
regression, these factors were independently associated with HBV infection
(p < 0.05). Sixty (80%) had not received prior HBV vaccination.
Unvaccinated personnel were more likely to be surgeons, dentists, < 37
years of age, and have fewer years of professional activity (p < 0.05).
After logistic regression, only fewer years of professional activity
remained independently associated with lack of vaccination (p < 0.05).
To reduce the occupational exposure of HBV, universal precautions must be
rigorously adhered to when the doctors and dentists carry out procedures on
their patients, and all health-care workers should be vaccinated with HBV
vaccine and the HCV vaccine, when it becomes available.
相似文献
107.
108.
A retrospective study of pretransfusion testing records compared the utility of the antiglobulin test (AGT) phase of the crossmatch and the autologous control (autocontrol) for detecting clinically significant alloimmunization to red cells (RBCs). Of 110,780 consecutive crossmatches, 141 were positive after a negative antibody screening test; only 4 of these were due to alloantibodies of potential clinical significance, for a predictive value of a positive AGT crossmatch, after a negative antibody screen, of 2.8 percent (4/141). The frequency of potentially shortened RBC survival was 1 in 27,685 units crossmatched. During a similar period, 56,090 autocontrols were performed with the antibody screen. The autocontrol was positive on 902 samples in which the antibody screen was negative. Antibody identification performed in 684 cases generally yielded only cold or warm autoagglutinins. In 96 cases, some form of alloantibody was detected, but only 25 had potential clinical significance by our criteria. Eight of these alloantibodies had concurrently caused in vivo sensitization of RBCs and were classified as delayed hemolytic transfusion reactions. The predictive value of the autocontrol, calculated as the number of significant alloantibodies detected in autocontrol-positive, antibody-screen-negative samples, was 3.6 percent (25/684). Inspection of these cases revealed 11 in which shortened RBC survival might have resulted if the serologic abnormality had not been detected. Thus, the autocontrol had a slightly greater yield of clinically significant findings than the AGT crossmatch.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
109.
Detecting fetomaternal hemorrhage: a comparison of five methods 总被引:3,自引:0,他引:3
KM Bayliss ; BD Kueck ; ST Johnson ; JT Fueger ; PW McFadden ; D Mikulski ; JL Gottschall 《Transfusion》1991,31(4):303-307
Appropriate postpartum administration of Rh immune globulin relies on sensitive detection and accurate quantitation of fetomaternal hemorrhage (FMH). Recently, the microscopic Du test (micro Du) enhanced with polyethylene glycol (PEG Du) and flow cytometry (FC) have been advocated for this purpose. Three qualitative methods (micro Du, rosette test, and PEG Du) and two quantitative methods (acid elution and FC) for assessing FMH were evaluated with particular attention given to PEG Du and FC. In vitro studies comprised 10 series of dilutions of D+ cord cells in D- adult cells to yield D+ cell concentrations of 0.06, 0.12, 0.25, 0.50, 0.75, 1.0, and 2.0 percent. Additionally, 26 postpartum samples were tested. Of the qualitative techniques, the micro Du test was the least sensitive with 20 percent false-negative results occurring at 0.5 percent fetal cells. The PEG Du test was only slightly more sensitive and offered no clinical advantage. The rosette test was the most sensitive, consistently detecting fetal cells at concentrations of 0.25 percent or greater. FC and acid elution showed similar results, with good correlation obtained between measured and expected quantities of fetal cells (r = 0.99 and 0.96, respectively). One of 26 postpartum samples was positive by all screening techniques; acid elution and FC detected 0.3-percent concentrations of fetal cells and 0.17-percent concentrations of D+ cells, respectively. Although acid elution is a more commonly used method for quantitating FMH, FC offers an acceptable alternative that is capable of analyzing large numbers of cells with objectivity and reproducibility. 相似文献
110.
Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide 总被引:3,自引:1,他引:3
Treatment with daily oral cyclophosphamide (CY) has improved survival in
Wegener's granulomatosis (WG), but is associated with severe and
potentially lethal adverse effects. Less toxic treatment regimens, such as
pulse CY, have been used, but the effect has been questioned. We have
treated 11 patients with WG with pulse CY (15 mg/kg initially every second
week, gradually increasing the pulse interval). After 4.5 yr follow-up and
a total of 501 pulses of CY, one patient died and eight patients (73%) were
in complete remission. Remission was induced in 91% of the patients after a
median period of 3.5 months and relapses were seen in 60%. With the same
treatment protocol, a new complete remission was induced in 75% of those
relapsing. Except for one patient who died, no patient developed end-stage
renal failure. Haemorrhagic cystitis was not observed and no malignancies
recorded. Severe infections were seen in 36%, but none caused by
Pneumocystis carinii. Nausea was the most frequent side-effect, seen in 64%
of the patients. We conclude that treatment with pulse CY every second week
is safe and effective in inducing remission and treating relapses in WG.
The relapse rate seems to be higher than with low-dose oral CY, but the
cumulative dose of CY is less.
相似文献